| Description | Geranylgeranyl pyrophosphate tetrabutylammonium(1：2) is one of the endogenous cholesterol and intermediates produced by the mevalerate pathway. Geranylgeranyl pyrophosphate tetrabutylammonium(1：2) is the common precursor of diterpenoids, for example, Paclitaxel. It can be used for cancer research. |
| Synonyms | Geranylgeranyl pyrophosphate tetrabutylammonium（1：2）(6699-20-3 Free base) |
| molecular weight | 933.35 |
| Molecular formula | C52H106N2O7P2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | Methanol: 50 mg/mL (53.57 mM), Sonification is recommended. DMSO: 50 mg/mL (53.57 mM), Sonication is recommended. |
| References | 1. Joseph C Utomo, et al. Developing a Yeast Platform Strain for an Enhanced Taxadiene Biosynthesis by CRISPR/Cas9. Metabolites. 2021 Mar 3;11(3):147. |